April 4, 2016

Pharmaceutical-Grade Supplements Now Available in US

The US launch of Pharma Nord's range of clinically tested and documented dietary supplements introduces a line of products that are bioavailable, safe and free of product contamination, adulteration and ingredient substitution

Marlton, NJ (April 2016). The US launch of Pharma Nord's range of clinically tested and documented dietary supplements introduces a line of products that are bioavailable, safe and free of product contamination, adulteration and ingredient substitution. Four out of five Pharma Nord supplements are registered as a drug in one or more countries, guaranteeing a documented, pharmaceutical-grade product without variation in active ingredients from batch to batch. 

Danish supplement and natural medicine manufacturer, Pharma Nord, Inc. enters the US market after 25 years of pioneering research in selenium and Coenzyme Q10 in the global marketplace. Pharma Nord was the first manufacturer to produce and sell CoQ10 in Europe before the product was introduced in the US market. Pharma Nord has a rich history of clinical trials and goes to extensive lengths to ensure products are tested  extensively through participation in double blind, placebo-controlled clinical trials globally. Pharma Nord's two flagships, Bio-Quinone Active CoQ10 Gold and SelenoPrecise (high-selenium yeast) are finally available for sale in the US through practitioners, health food stores and online at www.pharmanord.com

To protect the integrity of the pharmeutically-produced dietary supplements and to prevent deliquessence and/or contamination of the products, Pharma Nord blister packs every tablet and softgel. Answering to pharmaceutical production regulations and validation by The Danish Medicines Authority, Pharma Nord is able to guarantee the active ingredients in every product. Pharmaceutical production standards are enforced for every product even if it is sold as a dietary supplement. This standardization and ability to guarantee the active ingredient for the shelf life of the product has made Pharma Nord's products a preferred choice of clinical researchers and medical staff around the world, including the research team behind the acclaimed Q-Symbio clinical trial on CoQ10 and Chronic Heart Failure.

You can learn more about Pharma Nord's rich research history and the resources committed to making the products the market leaders in quality and bioavailabillity at www.pharmanord.com. Pharma Nord, Inc.'s US headquarters are located in Marlton, NJ 08053.

*Please note that these statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

 

Categorized Under